Skip to Content

Multikinase inhibitors

What are Multikinase inhibitors

Multikinase inhibitors work by inhibiting multiple intracellular and cell surface kinases, some of which are implicated in tumor growth and metastatic progression of cancer, thus decreasing tumor growth and replication. Multikinase inhibitors may be used to treat advanced kidney cancer as well as other specific types of cancer.

List of Multikinase inhibitors:

Filter by:
Drug Name DownUp( View by: Brand | Generic ) Reviews Ratings DownUp
crizotinib systemic (Pro, More...)
2 reviews
   
9.0
dabrafenib systemic (Pro, More...)
1 review
   
9.0
trametinib systemic (Pro, More...)
1 review
   
9.0
sunitinib systemic (Pro, More...)
19 reviews
   
7.4
vemurafenib systemic (Pro, More...)
3 reviews
   
7.2
ibrutinib systemic (Pro, More...)
10 reviews
   
6.9
sorafenib systemic (Pro, More...)
9 reviews
   
6.9
palbociclib systemic (Pro, More...)
19 reviews
   
6.3
axitinib systemic (Pro, More...)
0 reviews
   
6.0
afatinib systemic (Pro, More...)
1 review
   
5.0
ruxolitinib systemic (Pro, More...)
2 reviews
   
3.7
ponatinib systemic (Pro, More...)
2 reviews
   
3.0
regorafenib systemic (Pro, More...)
1 review
   
1.0
alectinib systemic (Pro, More...)
0 reviews
   
0.0
cabozantinib systemic (Pro, More...)
0 reviews
   
0.0
ceritinib systemic (Pro, More...)
0 reviews
   
0.0
cobimetinib systemic (Pro, More...)
0 reviews
   
0.0
idelalisib systemic (Pro, More...)
0 reviews
   
0.0
lenvatinib systemic (Pro, More...)
0 reviews
   
0.0
nintedanib systemic (Pro, More...)
0 reviews
   
0.0
ribociclib systemic (Pro, More...)
0 reviews
   
0.0
vandetanib systemic (Pro, More...)
0 reviews
   
0.0
Hide